Pieris Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Superior Medicines Through Efficient Biology
We combine leading protein engineering capabilities and deep insights into molecular drivers of disease to develop medicines that drive local biology to produce superior clinical outcomes.
Our Anticalin® Platform